Genetics Generation Advancement Corp. (TPEX:4160)
Taiwan · Delayed Price · Currency is TWD 44.85
+0.55 (1.24%)
Apr 1, 2026, 1:30 PM CST
TPEX:4160 Market Cap
TPEX:4160 has a market cap or net worth of 1.2 billion as of April 1, 2026. Its market cap has decreased by -36.29% in one year.
Market Cap
1.20B
Enterprise Value
867.75M
Revenue
603.11M
Ranking
n/a
PE Ratio
56.06
Stock Price
44.85
Market Cap Chart
Since July 15, 2011, TPEX:4160's market cap has increased from 957.80M to 1.20B, an increase of 24.98%. That is a compound annual growth rate of 1.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 1.20B | -9.94% |
| Dec 31, 2025 | 1.33B | -27.41% |
| Dec 31, 2024 | 1.83B | 85.27% |
| Dec 29, 2023 | 988.25M | 48.75% |
| Dec 30, 2022 | 664.37M | 10.48% |
| Dec 30, 2021 | 601.33M | 0.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 222.70B |
| Caliway Biopharmaceuticals | 134.02B |
| Bora Pharmaceuticals | 55.75B |
| Lotus Pharmaceutical | 54.40B |
| DV Biomed | 1.27B |
| Excelsior Biopharma | 1.26B |
| Meribank Biotech | 1.20B |
| Shangya Technology | 1.19B |